American International Group’s Argos Therapeutics, Inc. ARGS Stock Holding History

American International Group’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-336	Closed	-$3K	–	3221
2017 Q1	$3K	Buy	336 +29	+9%	+$1.83K	﹤0.01%	2997
2016 Q4	$30K	Hold	307	–	–	﹤0.01%	2940
2016 Q3	$30.6K	Hold	307	–	–	﹤0.01%	2973
2016 Q2	$37.6K	Sell	307 -318	-51%	-$42.5K	﹤0.01%	3001
2016 Q1	$80K	Buy	625 +44	+8%	+$3.56K	﹤0.01%	3588
2015 Q4	$27K	Buy	581 +306	+111%	+$25.9K	﹤0.01%	4184
2015 Q3	$27K	Buy	+275	New	+$32.6K	﹤0.01%	4185
2015 Q1	–	Sell	-3	Closed	-$660	–	5204
2014 Q4	$660	Sell	3 -7	-70%	-$1.26K	﹤0.01%	4903
2014 Q3	$2.01K	Hold	10	–	–	﹤0.01%	4820
2014 Q2	$1.61K	Hold	10	–	–	﹤0.01%	4788
2014 Q1	$2K	Buy	+10	New	+$2K	﹤0.01%	4682

Other funds holding ARGS

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

American International Group's ARGS Position: Q2 2017 in Review

American International Group sold out of Argos Therapeutics, Inc. (ARGS) in Q2 2017, closing a stake of 336 shares — an estimated $3K sold.

American International Group first reported a position in ARGS in Q1 2014 and held it in 11 quarters. The position peaked at $80K in Q1 2016. 34 funds tracked by Wall St. Rank hold ARGS as of Q2 2017.

American International Group reported no remaining Argos Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
American International Group sold 336 Argos Therapeutics, Inc. shares in Q2 2017, an estimated $3K.
American International Group first reported a position in Argos Therapeutics, Inc. in Q1 2014 and held it in 11 quarters.
American International Group's Argos Therapeutics, Inc. position peaked at $80K in Q1 2016.
34 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q2 2017.

Based on American International Group's 13F filing for Q2 2017, filed 11 Aug 2017.